When animal health companies expand globally, attention typically focuses on product registration, market access, supply chain planning, and commercialization. Medical information is often considered later in the process, positioned as a function that answers questions once products reach the market.
In practice, many organizations discover that supporting products globally is far more complicated than supporting their launch.
The challenge is not simply responding to inquiries in different countries. It is creating a medical information model that can support multiple species, product categories, customer groups, and regulatory requirements simultaneously.
Human pharmaceutical companies generally build programs around a single patient population. Animal health companies rarely have that luxury.
A single portfolio may include companion animal prescriptions, vaccines, diagnostics, biologics, specialty therapeutics, retail supplements and parasiticides, and livestock health products. Veterinarians, producers, distributors, retailers, and pet owners may use those products, each with different expectations and support needs.
As organizations grow, that complexity scales quickly.
One of the most common assumptions in global expansion is that a successful process in one market can simply be replicated in another.
Medical information rarely works that way.
The same product can generate very different types of inquiries depending on locale, customer type, and distribution model. In one region, veterinarians may contact the manufacturer directly. In another, distributors serve as the primary point of contact. Questions that are routine in one market may be uncommon in another because of differences in husbandry practices, prescribing habits, available formulations, or local regulations.
As a result, standardization and localization must be balanced.
Organizations need consistent processes for documentation, escalation, and compliance. At the same time, they need enough flexibility to account for differences in how information is requested, communicated, and used across markets.
Companies that underestimate that balance often create workarounds after launch instead of designing sustainable processes from the start.
Most animal health organizations don't lack information. They are struggling to connect it.
Inquiry records, adverse event reports, product quality complaints, customer feedback, scientific communications, and regulatory submissions often reside in different systems managed by different groups. Each function sees a portion of the picture, but few see the whole picture.
This becomes particularly difficult in animal health, where small signals may emerge across multiple channels before they become visible as a broader trend.
A veterinarian may report an unexpected outcome through medical information. Similar observations may be documented in adverse event reports. Additional context may appear in product complaints, technical service interactions, or field reports.
Individually, each record looks unremarkable; collectively, they may reveal something worth understanding.
Medical information's value isn't that it answers questions. In fact, every medical information team answers questions. The greater value is that medical information often has the broadest view of how customers experience a product after commercialization.
Medical information teams routinely interact with veterinarians, producers, distributors, and consumers. They hear where information is unclear, where training may be insufficient, where expectations differ from real-world use, and where operational processes create friction.
That perspective becomes increasingly important as portfolios grow and organizations expand internationally. Companies that treat medical information strictly as a transactional inquiry risk overlooking one of the few groups that routinely sees issues, trends, and customer experiences across product categories and regions.
As animal health companies continue to expand globally, the challenge will be designing programs that can operate effectively within the complexity of modern animal health portfolios.
That means building processes that can support multiple species, multiple customer groups, and multiple regulatory frameworks without creating unnecessary operational burden. It means improving the connections between medical information, pharmacovigilance, quality, and regulatory teams. And it means recognizing that the difficulty is not answering individual questions, but managing the volume, diversity, and interconnected nature of information generated throughout a product's lifecycle.
The organizations that do this well will not necessarily have the largest teams or the most sophisticated technology. They will be the organizations that design their operating models around the complexity of animal health portfolios.